Superior efficacy of a combined epigenetic therapy against human mantle cell lymphoma cells.
about
Combating the epigenome: epigenetic drugs against non-Hodgkin's lymphomaDeazaneplanocin a is a promising drug to kill multiple myeloma cells in their nicheRegulation and Role of EZH2 in Cancer3-Deazaneplanocin A (DZNep), an inhibitor of S-adenosylmethionine-dependent methyltransferase, promotes erythroid differentiation.FAS-antisense 1 lncRNA and production of soluble versus membrane Fas in B-cell lymphoma.Panobinostat reduces hypoxia-induced cisplatin resistance of non-small cell lung carcinoma cells via HIF-1α destabilizationInhibition of methyltransferases accelerates degradation of cFLIP and sensitizes B-cell lymphoma cells to TRAIL-induced apoptosisThe KDM2B- let-7b -EZH2 axis in myelodysplastic syndromes as a target for combined epigenetic therapyHistone methylases as novel drug targets: developing inhibitors of EZH2.EZH2 is increased in paediatric T-cell acute lymphoblastic leukemia and is a suitable molecular target in combination treatment approachesSynergistic activity of BET protein antagonist-based combinations in mantle cell lymphoma cells sensitive or resistant to ibrutinibHighly effective combination of LSD1 (KDM1A) antagonist and pan-histone deacetylase inhibitor against human AML cells.Combined inhibition of EZH2 and histone deacetylases as a potential epigenetic therapy for non-small-cell lung cancer cells.Targeting EZH2 for cancer therapy: progress and perspective.EZH2 enhances the differentiation of fibroblasts into myofibroblasts in idiopathic pulmonary fibrosis.LncRNA MALAT1 promotes development of mantle cell lymphoma by associating with EZH2.The polycomb group protein EZH2 is a novel therapeutic target in tongue cancer.A key role for EZH2 in epigenetic silencing of HOX genes in mantle cell lymphoma.Rhabdoid tumors: clinical approaches and molecular targets for innovative therapy.Targeting of cancer stem cells by inhibitors of DNA and histone methylation.Decoding the DNA Methylome of Mantle Cell Lymphoma in the Light of the Entire B Cell Lineage.Recent advances in SCF ubiquitin ligase complex: Clinical implicationsThe Polycomb group (PcG) protein EZH2 supports the survival of PAX3-FOXO1 alveolar rhabdomyosarcoma by repressing FBXO32 (Atrogin1/MAFbx).Acquired platinum resistance involves epithelial to mesenchymal transition through ubiquitin ligase FBXO32 dysregulationEfficacy of EZH2 inhibitory drugs in human papillomavirus-positive and human papillomavirus-negative oropharyngeal squamous cell carcinomas.Long Non-Coding RNAs Guide the Fine-Tuning of Gene Regulation in B-Cell Development and Malignancy
P2860
Q26851166-84527314-B625-4622-8046-8E5C7DDF1C75Q28543228-4354B73C-3206-47C4-A362-CAAE0BFB61B8Q34043370-FD073B94-5AF8-42CA-9C19-226828AB3B95Q34401976-852797E2-9595-4E54-815F-AAF3267F43F4Q34419383-41E38E84-32EB-490B-99ED-04A398CF00EAQ35059923-5D009242-F61B-448D-A41F-3EB4FBF140D5Q35147669-552851F7-1DBB-498B-BD0D-6AB0E63375D8Q35254822-2C5452E0-717F-448E-B4D3-6E5F2239F709Q35510392-05D5F5F7-4D08-4BE9-A818-BDE79244D8F2Q35949625-E3E41547-F559-48E0-9305-966B20124608Q36091288-828A1E9D-F2CC-47DA-A647-1273B5D6C680Q36539785-6B7DD8CF-4BBC-469E-9F34-FE67024B4860Q37098331-D99B2AED-A59E-45DB-B0C9-BA44C577CA05Q37204063-7FEF72F1-E312-4539-8EDE-319F67A20C0CQ37263917-2F285109-DA9C-45DE-896C-4D3D9FAEE6E0Q37523103-1FC1B683-69CD-43B1-8AE7-26FBEE0CB115Q37589165-A1756066-8635-46DF-AEEE-55ACF6B39BA4Q37600907-833B014C-372B-4EA4-8C39-D65D54C10D38Q38121136-E5A8AF0D-D24C-4ED1-A6EB-69318F42A911Q38500320-B43B72D1-3DC0-453E-A103-917378E858A5Q38730980-A7307044-EA45-4E87-AD9B-90D339D2FCE6Q38828721-516B204F-49C0-49B8-9F01-E66E7AE2C5E6Q39064876-C2B51BAE-D2C0-4D0B-95FC-32104BEDB1FAQ41612891-E10240C1-F454-432A-9378-8300E1DD9633Q41625850-8C6F206F-20AD-4C32-9F0C-28C8ECEA1093Q58725483-AC9C514D-836D-4E95-9636-0A2B7466BB4F
P2860
Superior efficacy of a combined epigenetic therapy against human mantle cell lymphoma cells.
description
2012 nî lūn-bûn
@nan
2012 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Superior efficacy of a combine ...... an mantle cell lymphoma cells.
@ast
Superior efficacy of a combine ...... an mantle cell lymphoma cells.
@en
type
label
Superior efficacy of a combine ...... an mantle cell lymphoma cells.
@ast
Superior efficacy of a combine ...... an mantle cell lymphoma cells.
@en
prefLabel
Superior efficacy of a combine ...... an mantle cell lymphoma cells.
@ast
Superior efficacy of a combine ...... an mantle cell lymphoma cells.
@en
P2093
P2860
P1476
Superior efficacy of a combine ...... an mantle cell lymphoma cells.
@en
P2093
Eduardo Sotomayor
Jacqueline E Smith
Jianguo Tao
Kapil Bhalla
Peter Atadja
Ramesh Balusu
Siddhartha Ganguly
Stacey L Hembruff
Uma Mudunuru
P2860
P304
P356
10.1158/1078-0432.CCR-12-0873
P407
P577
2012-08-29T00:00:00Z